The study has several implications. One, it’s more evidence that the atypicals,
once considered vastly superior to first-generation antipsychotics because of a
“favorable” side-effect profile, may not be that much better, just different.
Rather than risking tardive dyskinesia and akathisia as patients using first-gen
antipsychotics are, patients on atypicals risk major weight gain and metabolic
changes. …